K. Oki

Insider Reports History

Location
Bothell, WA
Signature
/s/ Sandra Thomson as attorney-in-fact for Mark Oki
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by K. Oki:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ACHIEVE LIFE SCIENCES, INC. Chief Financial Officer Performance Restricted Stock Unit (PRSU) 0 $617K $3.67 18 Sep 2025 Direct
ACHIEVE LIFE SCIENCES, INC. Chief Financial Officer Common Stock 128K $374K $2.92 18 Sep 2025 Direct
ACHIEVE LIFE SCIENCES, INC. Chief Financial Officer Common Stock Options (right to buy) 72K 06 Dec 2024 Direct
AYTU BIOPHARMA, INC Chief Financial Officer Employee Stock Option (Right to Buy) 13K 11 Aug 2023 Direct
ACHIEVE LIFE SCIENCES, INC. Chief Financial Officer No securities are beneficially owned 0 05 Dec 2024 Direct
ACHIEVE LIFE SCIENCES, INC. Chief Financial Officer Performance Restricted Stock Unit 0 04 Sep 2025 Direct

Insider Reports Filed by K. Oki

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACHV ACHIEVE LIFE SCIENCES, INC. 18 Sep 2025 3 -$146K 4 Chief Financial Officer 22 Sep 2025, 16:31
ACHV ACHIEVE LIFE SCIENCES, INC. 04 Sep 2025 1 $0 4 Chief Financial Officer 08 Sep 2025, 17:10
ACHV ACHIEVE LIFE SCIENCES, INC. 17 Mar 2025 1 $28.9K 4 Chief Financial Officer 19 Mar 2025, 16:38
ACHV ACHIEVE LIFE SCIENCES, INC. 06 Dec 2024 2 $0 4 Chief Financial Officer 09 Dec 2024, 16:39
ACHV ACHIEVE LIFE SCIENCES, INC. 05 Dec 2024 0 $0 3 Chief Financial Officer 09 Dec 2024, 16:37
AYTU AYTU BIOPHARMA, INC 11 Aug 2023 1 $0 4 Chief Financial Officer 15 Aug 2023, 19:28
AYTU AYTU BIOPHARMA, INC 18 Nov 2022 1 $20.7K 4/A Chief Financial Officer 28 Nov 2022, 15:30
AYTU AYTU BIOPHARMA, INC 17 Jan 2022 1 $0 4 Chief Financial Officer 19 Jan 2022, 10:42
AYTU AYTU BIOPHARMA, INC 17 Jan 2022 0 $0 3 Chief Financial Officer 19 Jan 2022, 10:40